SCHEMBL845245

SCHEMBL845245

CC(C)CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)CC(C)C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.50
ALDH1A1 P00352 4/20 0.47
GAA P10253 1/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2C9 P11712 1/20 0.47
NPC1 O15118 1/20 0.46
PABPC1 P11940 1/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 1/20 0.45
HCRTR1 O43613 2/20 0.44
HCRTR2 O43614 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845251 0.87 PABPC1 (0.50) ALDH1A1GAACYP2C19CYP2C9NPC1
SCHEMBL845228 0.85 HCRTR1 (0.49) ALDH1A1GAACYP2C19CYP2C9NPC1
SCHEMBL844899 0.85 NPC1 (0.52) ALDH1A1GAACYP2C19CYP2C9NPC1
SCHEMBL844890 0.84 KCNH2 (0.51) ALDH1A1CYP2C19CYP2C9NPC1PABPC1
SCHEMBL844894 0.84 CYP2C19 (0.55) ALDH1A1GAACYP2C19CYP2C9NPC1
SCHEMBL844902 0.84 ALDH1A1 (0.47) ALDH1A1GAACYP2C19CYP2C9NPC1
SCHEMBL845206 0.84 CYP2C9 (0.52) ALDH1A1GAACYP2C19CYP2C9NPC1
SCHEMBL845488 0.83 CYP2C19 (0.48) ALDH1A1CYP2C19CYP2C9NPC1PABPC1
SCHEMBL845202 0.83 CYP2C19 (0.48) ALDH1A1CYP2C19CYP2C9NPC1PABPC1
SCHEMBL845519 0.83 ALDH1A1 (0.46) ALDH1A1GAACYP2C19CYP2C9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed